Northern Trust’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $376K | Sell |
151,421
-226,789
| -60% | -$562K | ﹤0.01% | 3746 |
|
2025
Q1 | $586K | Sell |
378,210
-4,537
| -1% | -$7.03K | ﹤0.01% | 3509 |
|
2024
Q4 | $819K | Buy |
382,747
+37,633
| +11% | +$80.5K | ﹤0.01% | 3473 |
|
2024
Q3 | $1.5M | Buy |
345,114
+220,960
| +178% | +$961K | ﹤0.01% | 3163 |
|
2024
Q2 | $579K | Buy |
124,154
+20,122
| +19% | +$93.8K | ﹤0.01% | 3452 |
|
2024
Q1 | $527K | Sell |
104,032
-5,657
| -5% | -$28.7K | ﹤0.01% | 3544 |
|
2023
Q4 | $308K | Buy |
109,689
+40,269
| +58% | +$113K | ﹤0.01% | 3711 |
|
2023
Q3 | $199K | Buy |
69,420
+31,529
| +83% | +$90.5K | ﹤0.01% | 3816 |
|
2023
Q2 | $191K | Sell |
37,891
-92
| -0.2% | -$465 | ﹤0.01% | 3850 |
|
2023
Q1 | $71.8K | Hold |
37,983
| – | – | ﹤0.01% | 4169 |
|
2022
Q4 | $68.4K | Hold |
37,983
| – | – | ﹤0.01% | 4204 |
|
2022
Q3 | $64K | Buy |
37,983
+145
| +0.4% | +$244 | ﹤0.01% | 4252 |
|
2022
Q2 | $93K | Sell |
37,838
-152,108
| -80% | -$374K | ﹤0.01% | 4200 |
|
2022
Q1 | $527K | Sell |
189,946
-11,509
| -6% | -$31.9K | ﹤0.01% | 3719 |
|
2021
Q4 | $1.07M | Sell |
201,455
-1,999
| -1% | -$10.7K | ﹤0.01% | 3512 |
|
2021
Q3 | $1.72M | Sell |
203,454
-6,833
| -3% | -$57.8K | ﹤0.01% | 3359 |
|
2021
Q2 | $2.56M | Buy |
210,287
+16,543
| +9% | +$202K | ﹤0.01% | 3240 |
|
2021
Q1 | $4.7M | Sell |
193,744
-10,276
| -5% | -$249K | ﹤0.01% | 2784 |
|
2020
Q4 | $6.54M | Sell |
204,020
-1,723
| -0.8% | -$55.2K | ﹤0.01% | 2518 |
|
2020
Q3 | $6.22M | Buy |
205,743
+74,398
| +57% | +$2.25M | ﹤0.01% | 2396 |
|
2020
Q2 | $5.54M | Buy |
131,345
+8,839
| +7% | +$373K | ﹤0.01% | 2453 |
|
2020
Q1 | $3.06M | Buy |
+122,506
| New | +$3.06M | ﹤0.01% | 2603 |
|